Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A L Hillman

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|November 6, 1986
After the Challenger. Biomedical opportunities in spaceA L Hillman
Pharmacoeconomics|December 10, 1991
Idarubicin more cost-effective than daunorubicin?A L Hillman
HMO Practice|February 8, 1991
Disclosing information and treating patients as customers. A review of selected issuesA L Hillman
Consultant|June 8, 1989
Cost-containment incentives in HMOs. What's known, what's not knownA L Hillman
Health Affairs (Project Hope)|January 1, 1991
Managing the physician: rules versus incentivesA L Hillman
The New England Journal of Medicine|December 31, 1987
Financial incentives for physicians in HMOs. Is there a conflict of interest?A L Hillman
Health Services Research|May 5, 1998
Commentary: burden of proof in an era of outcomes research and managed careA L Hillman
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1994
Economic analysis of alternative treatments for persistent gastro-oesophageal reflux diseaseA L Hillman
Managed Care (Langhorne, Pa.)|May 8, 1995
It's time to tell patients the facts about managed careA L Hillman
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
The impact of physician financial incentives on high-risk populations in managed careA L Hillman
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|November 6, 1986
After the Challenger. Biomedical opportunities in spaceA L Hillman
Pharmacoeconomics|December 10, 1991
Idarubicin more cost-effective than daunorubicin?A L Hillman
HMO Practice|February 8, 1991
Disclosing information and treating patients as customers. A review of selected issuesA L Hillman
Consultant|June 8, 1989
Cost-containment incentives in HMOs. What's known, what's not knownA L Hillman
Health Affairs (Project Hope)|January 1, 1991
Managing the physician: rules versus incentivesA L Hillman
The New England Journal of Medicine|December 31, 1987
Financial incentives for physicians in HMOs. Is there a conflict of interest?A L Hillman
Health Services Research|May 5, 1998
Commentary: burden of proof in an era of outcomes research and managed careA L Hillman
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1994
Economic analysis of alternative treatments for persistent gastro-oesophageal reflux diseaseA L Hillman
Managed Care (Langhorne, Pa.)|May 8, 1995
It's time to tell patients the facts about managed careA L Hillman
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
The impact of physician financial incentives on high-risk populations in managed careA L Hillman
Pageof 7